Skip to Content

OMNICEF 300 mg Logo (Cefdinir 300 mg)

Pill imprint OMNICEF 300 mg Logo has been identified as Cefdinir 300 mg.

Cefdinir is used in the treatment of sinusitis; bronchitis; skin or soft tissue infection; skin and structure infection; strep throat (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Cefdinir 300 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Cefdinir 300 mg OMNICEF 300 mg  Logo
OMNICEF 300 mg
300 mg
Purple / Blue
Prescription only
Drug Class:
Third generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Dava Pharmaceuticals Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00074-3769 Abbott Laboratories
55289-0081 PDRX Pharmaceuticals Inc (repackager)
35356-0038 Lake Erie Medical and Surgical Supply (repackager)
55887-0187 Diversified Healthcare Services Inc (repackager)
54868-5767 Physicians Total Care Inc (repackager)
18837-0244 Innoviant Pharmacy Inc (repackager)
55289-0831 PDRX Pharmaceuticals Inc (repackager)
54868-4366 Physicians Total Care Inc (repackager)
54569-5214 A-S Medication Solutions, LLC (repackager)
66336-0104 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.